Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Accounts Payables (2018 - 2025)

Dna X (SONM) has disclosed Accounts Payables for 8 consecutive years, with $20.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accounts Payables rose 125.35% year-over-year to $20.4 million, compared with a TTM value of $20.4 million through Sep 2025, up 125.35%, and an annual FY2024 reading of $22.8 million, up 15.12% over the prior year.
  • Accounts Payables was $20.4 million for Q3 2025 at Dna X, down from $20.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $23.3 million in Q3 2023 and bottomed at $8.1 million in Q2 2022.
  • Average Accounts Payables over 5 years is $15.7 million, with a median of $16.3 million recorded in 2021.
  • The sharpest move saw Accounts Payables soared 157.23% in 2023, then tumbled 61.06% in 2024.
  • Year by year, Accounts Payables stood at $9.5 million in 2021, then surged by 123.01% to $21.1 million in 2022, then decreased by 6.05% to $19.8 million in 2023, then rose by 15.12% to $22.8 million in 2024, then fell by 10.68% to $20.4 million in 2025.
  • Business Quant data shows Accounts Payables for SONM at $20.4 million in Q3 2025, $20.6 million in Q2 2025, and $17.3 million in Q1 2025.